Register entry
Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven
- Registered sites
- 0
- Drug products
- 6
- Live patents
- 32
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
32Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| SILENOR | DOXEPIN HYDROCHLORIDE | May 2027 |
| SILENOR | DOXEPIN HYDROCHLORIDE | Jul 2027 |
| SILENOR | DOXEPIN HYDROCHLORIDE | Aug 2027 |
| SILENOR | DOXEPIN HYDROCHLORIDE | Jan 2028 |
| SILENOR | DOXEPIN HYDROCHLORIDE | Apr 2028 |
| SILENOR | DOXEPIN HYDROCHLORIDE | May 2028 |
| SILENOR | DOXEPIN HYDROCHLORIDE | Jun 2029 |
| SILENOR | DOXEPIN HYDROCHLORIDE | Sept 2030 |
Catalogue
Marketed products
6Showing 6 of 6.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Silenor | doxepin hydrochloride | TABLET | NDA |
| Silenor | doxepin hydrochloride | TABLET | NDA |
| Sumatriptan Succinate and Naproxen Sodium | sumatriptan succinate and naproxen sodium | TABLET | NDA AUTHORIZED GENERIC |
| Treximet | Sumatriptan Succinate and Naproxen Sodium | TABLET, FILM COATED | NDA |
| doxepin hydrochloride | doxepin hydrochloride | TABLET | NDA AUTHORIZED GENERIC |
| doxepin hydrochloride | doxepin hydrochloride | TABLET | NDA AUTHORIZED GENERIC |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.